Clinical Trial Update: Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether adding Wobe-Mugos E to chemotherapy improves outcomes in stage II/III multiple myeloma; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Drugs mentioned

• Chemotherapy (chemotherapy)
• Wobe-Mugos E

Snippet

Sponsor: Medsearch | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | Status: UNKNOWN